This study focuses on children with Chronic Kidney Disease (CKD) who have Iron Deficiency Anemia (IDA) or are at risk of developing it. IDA occurs when the body doesn’t have enough iron to produce adequate amounts of hemoglobin, a protein in red blood cells that carries oxygen throughout the body. The study aims to evaluate how well a medication called ferumoxytol works compared to another iron medication called iron sucrose.
The study will examine the safety and effectiveness of ferumoxytol, which is given as an intravenous solution (delivered directly into a vein). Participants will receive either ferumoxytol or iron sucrose over a period of 5 days. The treatment involves two doses of ferumoxytol or multiple doses of iron sucrose. The study will monitor how these medications affect the iron levels and blood counts in the participants’ bodies.
During the study, doctors will track changes in participants’ blood iron levels and hemoglobin (a protein that carries oxygen in the blood). They will also monitor for any side effects that may occur during or after the treatment. The study will pay special attention to how participants’ bodies respond to both medications, particularly regarding blood pressure and any allergic reactions.



Hungary
Lithuania
Poland